Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events understanding critical element search alzheimer’s disease treatments
Vagus Nerve Stimulation: Cost-Effective Treatment for Drug-Resistant Epilepsy Share on: September 17, 2018 Patients with drug-resistant epilepsy (DRE) utilize more health care resources and face higher costs than patients who can control their condition …
… utility values is a vital part of demonstrating a product’s value. We can help you evaluate your needs for utility … - Perform mapping to derive EQ-5D utility estimates from a disease-specific measure - Develop a health preference index … and standard gamble - Capture utility data real-time, as events occur, via mobile technology solutions (e.g., …
… to meet regulatory requirements for estimating the product's safety and/or effectiveness using real-world data (RWD). … medical records Administrative healthcare claims Disease-specific clinical registries Linkages of claims and …
… Mond T, Marshall G, Sweeney C, Davenport E, Wang J. @AANP_NEWS #AANP23 …
Decision-Analytic Model to Estimate Costs and Outcomes for Additional Screening for Ischemic Stroke Treatment OPPORTUNITY Our client wanted to understand if the costs of adding computed tomography perfusion ( CTP) or magnetic resonance imaging (MRI) to …
… Alzheimer's and Parkinson's Diseases (AD/PD) 2024 Share on: Tuesday, … will be presented at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD) 2024. Natural … history and clinical outcomes in patients with Alzheimer's disease-related psychosis in the United States. Rao S, Forns …
… 2019 Watch the recording When seeking approval for rare disease products, demonstrating value for therapies can be a … developing a rigorous economic model structure for rare disease research that can help you gain orphan drug … or ultra-orphan diseases? How do HTA bodies appraise rare disease drugs? What are the key challenges to developing …
… 2023 Non-small cell lung cancer (NSCLC) is an aggressive disease, with poor prognosis and a high likelihood of brain … duration of response, time-to-treatment discontinuation, disease control rate, and progression-free survival in a …
… Symposium on Merkel Cell Carcinoma (ISMCC 2022). Bhatia S, Nghiem P, Veeranki SP, Vanegas A , Lachance K, Tachiki L, …
… with dementia. The prevalence is higher in Parkinson’s and Alzheimer’s disease compared to other types of … the last 10 years. The main conclusions of our literature search are that: The majority of studies analyzing mortality …